These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Successful liver transplantation in a child with severe portopulmonary hypertension treated with epoprostenol. Laving A; Khanna A; Rubin L; Ing F; Dohil R; Lavine JE J Pediatr Gastroenterol Nutr; 2005 Oct; 41(4):466-8. PubMed ID: 16205516 [No Abstract] [Full Text] [Related]
17. Recurrent portopulmonary hypertension after liver transplantation: management with epoprostenol and resolution after retransplantation. Kett DH; Acosta RC; Campos MA; Rodriguez MJ; Quartin AA; Schein RM Liver Transpl; 2001 Jul; 7(7):645-8. PubMed ID: 11460234 [TBL] [Abstract][Full Text] [Related]
18. Hepatopulmonary syndrome and portopulmonary hypertension: recent knowledge in pathogenesis and overview of clinical assessment. Raevens S; Geerts A; Van Steenkiste C; Verhelst X; Van Vlierberghe H; Colle I Liver Int; 2015 Jun; 35(6):1646-60. PubMed ID: 25627425 [TBL] [Abstract][Full Text] [Related]
19. Portopulmonary hypertension in a patient of autoimmune hepatitis. Hira HS; Gupta M; Tyagi SK Indian J Chest Dis Allied Sci; 2005; 47(2):127-30. PubMed ID: 15832959 [TBL] [Abstract][Full Text] [Related]
20. Treatment of portopulmonary hypertension--isn't it time to move forward? Swanson KL Liver Transpl; 2008 Mar; 14(3):270-1. PubMed ID: 18306388 [No Abstract] [Full Text] [Related] [Next] [New Search]